-+ 0.00%
-+ 0.00%
-+ 0.00%

UPSTREAM BIO SHARES PLUNGE 20% PREMARKET AFTER CO REPORTS MID-STAGE ASTHMA DRUG TRIAL DATA

Reuters·02/11/2026 12:38:52

Please log in to view news